# clm_50DC2A117A21

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_net_income  
value: 2,967,000,000 United States dollar  
valid_from: 2024-06-30  
valid_to: 2024-09-30  
published: 2024-08-08  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_49D1BFE1C6AA  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly net income: 2,967,000,000 United States dollar", as of 2024-06-30 (until 2024-09-30). Claim clm_50DC2A117A21, https://asof.is/claim/clm_50DC2A117A21, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947824000187/0000059478-24-000187-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q2 FY2024, filed 2024-08-08  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947824000187/0000059478-24-000187-index.htm (primary, SEC EDGAR 10-Q Q2 FY2024, published 2024-08-08)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_net_income | 2,242,900,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_50DC2A117A21](/claim/clm_50DC2A117A21.md) | [clm_6D2F6DF42AAE](/claim/clm_6D2F6DF42AAE.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.